metformin and binimetinib

metformin has been researched along with binimetinib in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Akasov, R; Burov, S; Emelyanova, M; Inshakov, A; Khochenkov, D; Markvicheva, E; Prokofieva, A; Ryabaya, O; Stepanova, E	1

Other Studies

1 other study(ies) available for metformin and binimetinib

Article	Year
Metformin increases antitumor activity of MEK inhibitor binimetinib in 2D and 3D models of human metastatic melanoma cells. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2019, Volume: 109 Topics: Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Synergism; Humans; Hypoglycemic Agents; MAP Kinase Kinase 1; MAP Kinase Kinase 2; Melanoma; Metformin; Protein Kinase Inhibitors	2019

Article

Year

Metformin increases antitumor activity of MEK inhibitor binimetinib in 2D and 3D models of human metastatic melanoma cells.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2019, Volume: 109

Topics: Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Synergism; Humans; Hypoglycemic Agents; MAP Kinase Kinase 1; MAP Kinase Kinase 2; Melanoma; Metformin; Protein Kinase Inhibitors

2019